Global Neurorehabilitation Devices Market is valued approximately at USD 1378.9 million in 2018 and is anticipated to grow with a healthy growth rate of more than 15.50% over the forecast period 2019-2026. Neurorehabilitation devices are used in the treatment of the neurological disorders such as Alzheimer’s disease, migraine, Parkinson’s, epilepsy, brain stroke, multiple sclerosis, neurodegeneration etc. Neurorehabilitation helps in improving the functions, reducing the symptoms and also in improving the well-being of the patients suffering from neurological diseases. There has been rising prevalence of neurological diseases which has led to the increased adoption of neurorehabilitation devices for diagnosis and treatment of neurological diseases.
According to World Health Organization (WHO), approximately 6 million deaths occur due to stroke each year. Furthermore, as per WHO, epilepsy is a common neurological disease and approximately 50 million people (as in 2016) globally suffer from epilepsy and 2.4 million people are diagnosed with epilepsy each year. According to world economic forum, the numbers of Parkinson’s disease patients are expected to reach 8.7 million worldwide by 2030 as compared to 4.1 million in 2005. Increasing prevalence of neurological diseases, geriatric population and Emergence of wearables and robotics are key driving factors for market growth. Moreover, rising patient base in emerging economies is expected to create significant growth opportunity in the market over the forecast period. However, High cost of treatment impedes the growth of the market over the forecast period of 2019-2026.
The regional analysis of global Neurorehabilitation Devices market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the growing prevalence of neurological diseases coupled with the well-established healthcare infrastructure. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2019-2026. Factors such as rising incidences of neurological disorders coupled with increasing geriatric population and improving healthcare infrastructure would create lucrative growth prospects for the Neurorehabilitation Devices market across Asia-Pacific region.
Get Sample Copy Of Market Report: https://www.sdki.jp/sample-request-58926
Major market player included in this report are:
Bioxtreme Robotics Rehabilitation
Ekso Bionics Holdings, Inc.
Helius Medical Technologies
Neurostyle Pte, Ltd.
St. Jude Medical, Inc. (Acquired by Abbott Laboratories)
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.
The detailed segments and sub-segment of the market are explained below:
Spinal Cord Injury
Traumatic Brain Injury
Cognitive Care Centers
Rest of the World